EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value

Inas Alhudiri, Christopher Nolan, Ian Ellis, Adam Elzagheid, Andrew Green, Caroline Chapman

Breast Cancer Research and Treatment · 2024

DOI: 10.1007/s10549-024-07293-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2024. Verfasst von Inas Alhudiri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Breast Pathology Research Group, Nottingham Breast Cancer Research Centre, Biodiscovery Institute, Faculty of Medicine, The University of Nottingham,…. Hauptthemen laut MEDLINE: Cathepsin D, Breast Neoplasms, Biomarkers, Tumor, Neoplasm Staging. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Cathepsin D is a proteolytic enzyme that is normally localized in the lysosomes and is involved in the malignant progression of breast cancer. There are conflicting results regarding Cathepsin D significance as prognostic and predictor marker in breast cancer. This study aimed to evaluate the expression and prognostic significance of Cathepsin D in early-stage breast cancer.

Methods

Expression of Cathepsin D was assessed by immunohistochemical staining of tissue microarrays, in a large well-characterized series of early-stage operable breast cancer ( n = 954) from Nottingham Primary Breast Carcinoma Series between the period of 1988 and 1998 who underwent primary surgery. Correlation of Cathepsin D expression with clinicopathological parameters and prognosis was evaluated.

Results

Cathepsin D expression was positive in 71.2% (679/954) of breast cancer tumours. Positive expression of Cathepsin D was significantly associated with high histological grade ( p = 0.007), pleomorphism ( p = 0.002), poor Nottingham Prognostic Index (NPI) score ( p < 0.002), recurrence ( p = 0.005 ) and distant metastasis ( p < 0.0001). Kaplan–Meier analysis showed that Cathepsin D expression was significantly associated with shorter breast cancer-specific survival ( p = 0.001), higher risk of recurrence ( p = 0.001) and distant metastasis ( p < 0.0001). ER-positive tumours expressing Cathepsin D and treated with tamoxifen demonstrated a significantly higher risk of distant metastasis.

Conclusion

Cathepsin D expression significantly predicts poor prognosis in breast cancer and is associated with variables of poor prognosis and shorter outcome. The strong association of Cathepsin D with aggressive tumour characteristics and poor outcomes warrants further research of its potential as a therapeutic target The results also suggest a possible interaction between Cathepsin D and tamoxifen therapy in ER-positive breast cancer which needs further investigation to elucidate the underlying mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cathepsin DBreast NeoplasmsBiomarkers, TumorNeoplasm StagingHumansFemalePrognosisMiddle AgedAdultAgedKaplan-Meier EstimateTissue Array AnalysisImmunohistochemistryAged, 80 and overNeoplasm Grading

Stichwörter der Autor:innen

Breast cancerCathepsin DImmunohistochemistryPrognosisTissue microarray

Substanzen

Cathepsin DBiomarkers, TumorCTSD protein, human

Autor:innen und Institutionen

  • Breast Pathology Research Group, Nottingham Breast Cancer Research Centre, Biodiscovery Institute, Faculty of Medicine, The University of Nottingham, Nottingham, UK.
  • Genetic Engineering Department, Libyan Biotechnology Research Centre, Tripoli, Libya.
  • Breast Pathology Research Group, Nottingham Breast Cancer Research Centre, Biodiscovery Institute, Faculty of Medicine, The University of Nottingham, Nottingham, UK. andrew.green@nottingham.ac.uk.
  • Eastern Bowel Cancer Screening Hub, Nottingham University Hospitals, NHS Trust, Nottingham, UK.

Zitieren

APA

Alhudiri, I., Nolan, C., Ellis, I., Elzagheid, A., Green, A., & Chapman, C. (2024). Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07293-y

Vancouver

Alhudiri I, Nolan C, Ellis I, Elzagheid A, Green A, Chapman C. Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value. Breast Cancer Research and Treatment. 2024. doi:10.1007/s10549-024-07293-y

BibTeX
@article{Alhudiri2024,
  author = {Alhudiri, Inas and Nolan, Christopher and Ellis, Ian and Elzagheid, Adam and Green, Andrew and Chapman, Caroline},
  title = {Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value},
  journal = {Breast Cancer Research and Treatment},
  year = {2024},
  doi = {10.1007/s10549-024-07293-y}
}
Kostenlos starten →